Company facts
- Headquarters
- London
- Most recent report
- 10-Q, filed Aug 11, 2026
- Filings on record
- 329 filings
- On EDGAR
- CIK 1730463
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 69
News 8 of 47
- 8-K Quarterly results Aug 11, 2026
- 8-K Other events Aug 3, 2026
- 8-K Significant contract Aug 3, 2026
- 8-K Shareholder vote results Jun 29, 2026
- 8-K Other events Jun 9, 2026
- 8-K Quarterly results May 14, 2026
- 8-K Current report on a material event Apr 29, 2026
- 8-K Current report on a material event Apr 16, 2026
Prospectuses and Registrations 8 of 39
- S-3 Shelf registration statement Apr 13, 2026
- S-3 Shelf registration statement Apr 13, 2026
- 424B3 Prospectus supplement for an offering Jan 26, 2026
- 424B3 Prospectus supplement for an offering Jan 12, 2026
- 424B3 Prospectus supplement for an offering Dec 2, 2025
- S-8 Registration statement for an employee plan Nov 18, 2025
- 424B3 Prospectus supplement for an offering Nov 12, 2025
- 424B3 Prospectus supplement for an offering Aug 12, 2025
Ownership 8 of 102
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- 4 Insider reported a trade Jul 1, 2026
- 4 Insider reported a trade Jul 1, 2026
- 4 Insider reported a trade Jul 1, 2026
- 4 Insider reported a trade Jul 1, 2026
- 4 Insider reported a trade Jul 1, 2026
- 4 Insider reported a trade Jul 1, 2026
- 4 Insider reported a trade Jul 1, 2026
Other 8 of 72
- EFFECT Notice that a registration became effective May 5, 2026
- EFFECT Notice that a registration became effective May 5, 2026
- CORRESP Reply to SEC staff May 1, 2026
- CORRESP Reply to SEC staff May 1, 2026
- UPLOAD Comment letter from SEC staff Apr 15, 2026
- UPLOAD Comment letter from SEC staff Apr 15, 2026
- DEL AM Apr 15, 2026
- DEL AM Apr 15, 2026
Everything here comes from Autolus Therapeutics plc's own filings on SEC EDGAR. The filing list is rechecked every hour.